UNSPSC 51131729: Lamifiban

This classification denotes an antiplatelet agent with the molecular formula C24H28N4O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9XOE28082S, chemically known as acetic acid, ((1-(2-((4-aminoiminomethyl)benzoyl)amino)-3-(4-hydroxyphenyl)-1-oxopropyl)-4-piperidinyl)oxy)-, (s)- but generally known as lamifiban, which bears US NIH Compound Identifier 71453. European Medicines Agency schedules Lamifiban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08391MIG.

UNSPSC 51131729 Lamifiban is a Commodity code with no recent state and local procurement activity that reflects the product's actual scope. The single recent solicitation tagged under this code—Sourcewell RFP #061626 for Law Enforcement Equipment—does not involve lamifiban or related pharmaceutical products; it solicits equipment for law enforcement agencies. State and local procurement offices do not appear to be actively buying lamifiban through posted contract opportunities at present.

The mismatch between the code's pharmaceutical scope and the law enforcement equipment solicitation suggests either a tagging error in the opportunity record or minimal current activity in state and local lamifiban procurement. Without representative solicitations grounded in actual lamifiban purchases, market characterization by issuing body, geographic spread, or procurement pattern cannot be reliably drawn. Firms evaluating this code should confirm directly with state pharmacy benefit managers, Medicaid agencies, or regional health systems whether lamifiban contracting activity is posted under alternate codes or conducted through established standing agreements rather than open solicitations.